Improvement of cardiac glycoside therapy
Rösner, K.
Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(12): 337-338
1979
ISSN/ISBN: 0044-2542 PMID: 506349 Document Number: 147710
Document emailed within 1 workday
Related Documents
Schwarzfischer, V.P. 1976: Serum glycoside level in old age. Problems of course control in glycoside therapy Fortschritte der Medizin 94(14): 841-846Raschack, M.; Haas, H.; Neugebauer, G.; Sipos, J. 1978: Cardiac effects, relative enteral effectiveness and rate of inactivation of the cardiac glycoside meproscillarin Arzneimittel-Forschung 28(3a): 495-502
Larbig, D. 1982: Value and indications for the determination of cardiac glycoside levels Fortschritte der Medizin 100(38): 1749-1752
Bonelli, J.; Waginger, W.; Gazo, F. 1988: The bioavailability of methylepoxyproscillaridin (P35): a new semisynthetic cardiac glycoside International Journal of Clinical Pharmacology Therapy and Toxicology 26(6): 297-299
Mikhaĭlov, I.B. 1988: Treatment of cardiac glycoside poisoning (review of the literature) Vrachebnoe Delo 1988(5): 39-41
Wallick, E.T.; Lindenmayer, G.E.; Lane, L.K.; Allen, J.C.; Pitts, B.J.; Schwartz, A. 1977: Recent advances in cardiac glycoside-Na+,K+-ATPase interaction Federation Proceedings 36(9): 2214-2218
Brain, C.; Fox, V.E. 1994: Suspected cardiac glycoside poisoning in elephants (Loxodonta africana) Journal of the South African Veterinary Association 65(4): 173-174
Kirmizibekmez, H.; Taşdemir, D.; Ersöz, T.; Ireland, C.M.; Caliş, I. 2002: A new pregnane glycoside and a furostanol glycoside from Digitalis cariensis Die Pharmazie 57(10): 716-720
Ochs, H.R.; Bodem, G.; Schlehbusch, H.; Nuppeney, M.; Baur, M.P.; Oberhoffer, G. 1978: The clinical significance of plasma glycoside concentrations in patients with cardiac pacemakers Zeitschrift für Kardiologie 67(2): 109-115
Möller, R. 1975: Cardiac glycoside-induced inhibition of membrane ATPase as a cause of digitalis intoxication Medizinische Klinik 70(27): 1166-1173
Drzewoski, J.; Szczepańska, J.; Brodowski, L. 1979: Usefulness of erythrocytic sodium and potassium determination in the diagnosis of cardiac glycoside toxicity Polski Tygodnik Lekarski 34(6): 203-206
Tanz, R.D.; Russell, N.J. 1983: Mechanism of cardiac glycoside-induced toxicity: physiology, biochemistry, and electron microscopy Federation Proceedings 42(8): 2470-2474
Tatochenko, Z.A.; Riabinskaia, T.F.; Frenkel', V.K.; Strongina, E.I.; Tal'pis, B.L. 1976: Characteristics of cardiac glycoside treatment of circulatory insufficiency in young children with acute pneumonia Pediatriia 10: 33-37
Kubicek, F. 1983: Alternatives to glycoside therapy? Wiener Klinische Wochenschrift 95(17): 607-611
Erdmann, E.; Schoner, W. 1974: Correlation of cardiac glycoside binding to their receptors and inhibition of (Na + K)-active ATPase. Clinical significance and application possibilities Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1075-1077
Dietmann, K. 1977: Glycoside therapy in coronary disease Wiener Medizinische Wochenschrift 127(20): 627-630
Jordan, D.; Junge, N.; Schröder, K.; Schulz, K.; Spangenberg, K.; Wüstenberg, P.W. 1975: Standardized prescription glycoside: results of prescription analysis and clinical observations (glycoside intoxication) Zeitschrift für Arztliche Fortbildung 69(19): 1017-1021
Bock, K. 1985: Glycoside therapy--indications and dosage in childhood Kinderarztliche Praxis 53(8): 371-373
Georgievskii, V.P.; Kazarinov, M.O.; Puchkova, E.I. 1972: Use of chromatography on thin sorbent layers for controlling the quality of phytochemical preparations and plant raw materials. I. Some characteristics of the relationship of structure to cardiac glycoside genins Farmatsevtychnyi Zhurnal 27(3): 54-59
Kuhlmann, J.; Rietbrock, N. 1976: Glycoside-plasma level under maintenance therapy--dispersion of the concentrations and its causes Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1704-1709